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ABSTRACT
Naturally occurring dietary phytochemicals have been recognized as possessing many health-promoting effects. Recent studies suggest that inflammation is closely related to chronic disease, including cancer, atherosclerosis, neurodegeneration, obesity,
diabetes, asthma, articular rheumatism, and skin-aging. Extracellular stimuli transmit signals into a cell by activating the target
kinases involved in inflammation and the onset of chronic diseases. Phytochemicals can directly bind to specific proteins involved in intracellular signaling networks and regulate their activity, leading to diverse physiological effects. A better understanding of the direct interactions between phytochemicals and target proteins would contribute to development of nutritional
strategies for preventing or delaying the development of chronic diseases. In this review, recently identified molecular targets and
signaling pathways regulated by phytochemicals will be discussed.
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INTRODUCTION
Phytochemicals, widely known as the most common antioxidants in fruits and vegetables, have been proposed as
primary chemopreventive agents. Polyphenols, the major
group of phytochemicals, are characterized by the presence
of more than one phenol unit or building block per molecule(1).
Uncontrolled inflammation often results in chronic diseases such as arthritis, autoimmune disorders, cancer, obesity, diabetes, and neurodegenerative and vascular disease(2). Multiple lines of inquiry have suggested that the
health benefits of phytochemicals come from their anti-oxidant effects. However, the antioxidant properties of
phytochemicals cannot explain all of their effects, such as
specific inhibition of signal transduction and low effective
dose. Numerous studies have reported that phytochemicals
modulate various molecular signal transduction pathways,
and research efforts have focused on the effects of phytochemicals on signaling cascades. However, the specific
cellular and molecular targets of phytochemicals remain to
be identified.
After the success of tamoxifen and finasteride, which
have specific molecular targets, the development of recent
cancer preventive agents has been based on the discovery
of precise molecular targets(3). Targeting several signaling
pathways simultaneously using phytochemicals to achieve
synergistic effects in cancer treatment has been investigated, but the efficacy of this concept for obesity or neu-

rodegenerative diseases has not been as rigorously explored. This review focuses on recent studies of molecular
targets of natural phytochemicals in cancer, obesity, and
Alzheimer’s disease.

IMPORTANCE OF PHYTOCHEMICALS FOR
CANCER, OBESITY, AND ALZHEIMER’S
DISEASES
I. Signaling Pathways and Potential Molecular Targets for
Phytochemicals in Carcinogenesis
Despite an enormous amount of research and rapid
developments, cancer is still a leading cause of death
worldwide. The lack of a ‘magic bullet’ has led to
increased interest in chemoprevention as an alternative
approach to the control of cancer. Epidemiological studies
have shown that diets rich in polyphenols are associated
with a lower risk of cancer developments(4,5). On this basis,
attention has focused on dietary phytochemicals as an
effective intervention in cancer development.
Chemoprevention is defined as a pharmacological
approach used to arrest or reverse cancer development
before invasion and metastasis occur(6). Chemotherapy of
earlier stages of cancer, before invasion, has been
relatively more successful. Therefore, researchers already
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possess the means to suppress cancer in its early,
premalignant stages, before invasion and metastatic
malignancy. An approach to cancer suppression that
prevents carcinogenesis in its early stages is a logical, and
perhaps the best, strategy to reduce the overall cancer risk.
There are various signaling pathways involved in
inflammation. NF-κB and COX-2 are the major molecules
that mediate inflammation(7). Interactions of prostaglandins
with their receptors to enhance cellular survival or
stimulate angiogenesis have been proposed as the
molecular mechanisms underlying the pro-carcinogenic
roles of COX-2. LPS and TNF-α are the best studied
inducers of COX-2(8).
Extracellular stimuli can activate numerous membrane
receptors, such as EGFR, which convert these stimuli into
various intracellular signals through activation of Src
family kinases (SFK). Once activated, SFK transmits
signals to various pathways(9). SFK expression and activity
are related to the development of malignancy in various
human cancers. Previous studies have indicated that SFKs
are associated with the activation of MAPKs, PI3K, and
NF-κB signaling pathways. SFKs are, therefore,
considered to be good targets for therapy(10,11).
II. Processes and Potential Molecular Targets for
Phytochemicals in Adipogenesis
Obesity is a risk factor for diseases like diabetes,
atherosclerosis, and certain cancers. Adipose mass can be
decreased by reducing adipocytes, and adipogenesis is
related to adipocyte differentiation and maturation. Although apoptosis of adipocytes is one strategy to treat obesity, it has the potential for side-effects. Moreover, there is
space remaining after apoptosis of a large adipocyte,
which new small adipocytes will fill. Because adipogenesis represents the early stage of fat formation, inhibition of
adipogenesis pathways may be effective for treating obesity.
The first feature of the adipogenesis process is an
alteration in cell shape paralleled by changes in the type
and expression levels of extracellular matrix and cytoskeletal components(12). These events further promote the
expression of adipogenic transcription factors, including
the central transcriptional regulators of adipogenesis,
C/EBPα and PPAR γ. AMP-activated protein kinase
(AMPK) is another target molecule for antiobesity treatments, since its activation inhibits adipogenesis differentiation.
III. Processes and Potential Molecular Targets for
Phytochemicals in Alzheimer’s Disease (AD)
Alzheimer’s disease (AD) is an age-related
neurodegenerative disease increasingly recognized as one
of the most important medical problems affecting the
elderly. Amyloid-ß (Aß) plays a critical role in the
neuronal and synaptic degeneration of the brain regions
implicated in learning and memory. The amyloid
hypothesis suggests that abnormal proteolytic cleavage of
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amyloid precursor protein (APP) by ß- and γ-secretase
leads to excessive extracellular accumulation of Aß in the
AD brain(13). Excessive Aß aggregation might directly
interact with neuronal membranes or indirectly stimulate
diverse signaling pathways to impair neuronal synapses
and dendrites, and cause local oxidative stress reactions
and sustained inflammatory responses(14). New approaches
for preventing and treating AD have emphasized strategies
to reduce the pathogenesis of Aß.
The central nervous system is rich in polyunsaturated
fatty acids and has a high content of transition metals and
ascorbate, which together act as potent pro-oxidants(15).
Reactive oxygen species (ROS) and reactive nitrogen
species cause injury to the brains of AD patients during the
early development of the disease. Importantly, oxidative
stress has been shown to precede the formation of senile
plaques in the brain, the neuropatholgical hallmark of
AD(16). Markers of oxidative stress have been observed in
the brains of AD patients. Thus, antioxidant enzymes and
antioxidants have been demonstrated to protect against
Aß-induced cytotoxicity.
Recent studies suggest that inflammation may be one
of the major contributors to the progression and chronicity
of AD(17). Fibrillar Aß can bind to the complement factor
C1 and potentially activate the classical complement
pathway, which plays an important role in local
recruitment and activation of microglia. Aß can activate
microglia directly by binding to the lipopolysaccharide
(LPS) receptor CD14 or other scavenger receptors.
Activated microglia induce the release of large amounts of
pro-inflammatory mediators(17). The potentially significant
contribution of inflammatory mechanisms to the
progression and chronicity of AD has prompted
consideration of anti-inflammatory treatment strategies.

SELECTED DIETARY PHYTOCHEMICALS FOR
PREVENTION OF CARCINOGENESIS,
ADIPOGENESIS, AND AD
I. Anticarcinogenic Agents
Many researchers have attempted to identify novel
polyphenols that have chemopreventive effects by
targeting various oncogenic pathways. We will discuss the
effects of representative examples that reversibly inhibit
various carcinogenic pathways.
Resveratol, cyanidin and delphinidin are well-known
polyphenols in red wine, grapes, and berries, which act as
direct signaling regulators in carcinogenesis. COX-2 and
LTA4H are the molecular targets of resveratrol for the
inhibition of colon and pancreatic cancer proliferation.
Cyanidin suppresses COX-2 expression by directly
targeting Raf, MKK4, and MEK1. Delphinidin attenuates
COX-2 expression and neoplastic transformation.
Molecular targets of delphinidin include Fyn, Raf, MEK1,
ERKs, MKK4, and PI3K(3).
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Various isoflavones in soybean and their metabolites,
such as genistein, 7,3′ ,4′ - trihydroxy- isoflavone
(7,3′ ,4′ -THIF) and equol, also inhibit diverse signaling
pathways. Genistein suppresses EGFR kinase activity in
A431 cells. Equol and 7,3’,4’-THIF, metabolites of
daidzein, inhibit neoplastic cell transformation by targeting
MEK1 and PI3K, respectively, in JB6 P+ cells(9).
5-deoxykaempferol (5-DK), kaempferol, quercetin,
and myricetin are flavonols, and directly inhibit multiple
protein kinases involved in the signaling cascades in
carcinogenesis. 5-DK has a chemopreventive effect on
UVB-induced COX-2 and VEGF expression by targeting
Src, PI3K, and RSK in vitro and in vivo. Keampferol
exerts a strong protective effect against UVB-induced skin
carcinogenesis by targeting Src. RSK and PI3K are also
direct targets of Keampferol in cell proliferation and
neoplastic transformation. Quercetin inhibits COX-2
expression and cell transformation by targeting PI3K and
Raf, respectively, in JB6 P+ cells. Myricetin is a
multi-target agent that inhibits skin carcinogenesis,
metastatic phenotypes, and cell transformation by targeting
Fyn, Raf, MKK4, MEK1, JAK1, and PI3K(9).
In general, synthetic cancer drugs target one protein
because they have a high specificity, and that specificity
causes side-effects, including high toxicity and drug
resistance(3). However, dietary phytochemicals are very
effective for overcoming this difficulty because of their
low toxicity and multi-target signal inhibition.
II. Anti-Adipogenic Agents
Phytochemicals have the potential to inhibit
differentiation of pre-adipocytes, stimulate lipolysis, and
induce apoptosis of existing adipocytes, thereby reducing
the amount of adipose tissue. Several polyphenolic
phytochemicals target the adipocyte life cycle. Inhibition
of adipocyte differentiation is likely to be the safest and
most effective strategy.
A number of studies have demonstrated that natural
compounds, such as EGCG, genistein, resveratrol, CLA,
capsaicin, and procyanidins, inhibit adipogenesis. The
protein expression of PPAR and C/EBP was decreased in
adipocytes treated with capsaicin, genistein, and EGCG.
The decrease in adipogenesis caused by resveratrol was
associated with increased expression of Sirt1, which promotes fat mobilization by repressing PPARγ. Genistein,
EGCG and capsaicin inhibit adipocyte differentiation by
activating AMPK(18).
Some studies indicated that synergistic effects on
adipocytes could be achieved by using lower doses of two
or more compounds, thereby decreasing potential toxic
effects(19). In order to develop an effective mixed treatment,
target-based studies of natural anti-obesity agents are
needed.
III. Anti-AD Agents
Epidemiological studies have suggested a positive
relationship between consumption of curcumin, green tea
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catechins and prevention of AD(20). Curcumin, the active
component of the turmeric Curcuma longa, exerts
anti-oxidant and anti-inflammatory effects. Its use has
been proposed in the therapy of neurodegenerative
disorders. Curcumin blocks the formation of Aß fibrils.
Although the precise anti-amyloidogenic mechanism of
curcumin is unclear, it has been suggested that curcumin
might be capable of specifically binding free Aß and
subsequently inhibiting polymerization of Aß into Aß
fibrils. Curcumin also inhibits Aß-induced cytokines and
chemokines by suppressing lipoxygenase, COX-2, and
NF-κB activation. Curcumin exhibits a strong antioxidant
effect, and exerts its preventive effect by inducing
expression of the antioxidant enzyme, heme oxygenase-1
(HO-1), and glutathione S-transferase(21,22).
Green tea catechins have been reported to activate
MAPKs, protein kinase C, antioxidant enzymes and
survival genes, and to control calcium homeostasis and
APP processing. EGCG, a major polyphenolic catechin in
green tea, reduced Aß generation and plaques in vitro and
in vivo by activating α-secretase activity and reducing that
of ß-secretase. EGCG attenuates preformation or
formation of Aß fibrils by directly binding to the native
unfolded Aß. EGCG also decreases malondialdehyde
levels and caspase activity, protecting against Aß-induced
apoptosis and enhancing hippocampal neuronal survival
(21,23)
.
Many researchers have demonstrated the inhibitory
effect of dietary phytochemicals on neurodegeneration in
vitro and in vivo. However, studies aiming to elucidate the
targets of phytochemicals effective against AD have thus
far been insufficient. Discovery of the molecular targets of
polyphenolic natural compounds will provide an effective
and safe solution to the problem of preventing Alzheimer’s
disease.

CONCLUSIONS
Using a combination of agents or a multi-targeted
approach provides synergistic or additive preventive effects
with the lowest active dose of each agent and so lowers the
risk of adverse side effects. There is a trend towards
personalized treatment as a requirement for effective human
disease therapy, especially cancer. Conversely, a
personalized diet for prevention of human chronic diseases
has not been as well-documented, although prescribing a
personalized diet for chronic diseases might make sense. In
order to achieve this, it is first necessary to elucidate the
precise molecular targets of phytochemicals.
Although there have been many reports of the benefits
and targets of phytochemicals, these have relied mainly on
cell and animal models. In order to apply phytochemicals as
personalized preventive agents, their effects on humans must
be assessed in clinical trials. In the future, personalized
prevention methods using phytochemicals may have a
crucial role in human disease. Rigorous research aiming to
identify molecular targets, and conducting human studies
with phytochemicals, would provide an effective approach to
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personalized treatment and diet.
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